Indapta Therapeutics is based in San Francisco. It has raised $73M in total funding. Latest round: Series A.
Indapta Therapeutics is based in San Francisco. Indapta Therapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Indapta Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, LP, Vertex Ventures HC, Leaps By Bayer, Myeloma Investment Fund, Lonza, Pontifax. 6 distinct backers are named across the disclosed rounds.
Every Indapta Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026